DiagnoCure Inc.

Ordinary Shares International Reporting
OTC Pink Current Information
Contact Info
  • 4535 Wilfrid-Hamel Blvd.
  • Suite 250
  • Quebec City, QC G1P 2J7
  • Canada

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status International Reporting: Toronto Stock Exchange
Latest Report Jan 31, 2016 Quarterly Report
Fiscal Year End 10/31
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 2835 - Diagnostic substances
Business Status Development Stage Company a/o
Incorporated In: Quebec, Canada
Year of Inc. 1994
Employees 12 a/o Jan 31, 2013
Company Officers/Contacts
Dr. Yves Fradet CEO, CSO
Frederic Boivin Director, Fin., Acting CFO
Company Directors
Dr. Yves Fradet Chairman
Dr. Vincent R. Zurawski, Jr.
Dr. Louise Proulx
Dr. Jacques Simoneau
Service Providers
Accounting/Auditing Firm
Ernst & Young LLP
Ernst & Young Tower
222 Bay St.
Toronto, ONT, M5K 1J7

Legal Counsel
McCarthy Tetrault LLP
700-1150 de Claire Fontaine
Quebec City, QC, G1R 5G4

Investor Relations Firm
Not Available
DGCRF Security Details
Share Structure
Market Value1 $25,824 a/o Aug 21, 2017
Authorized Shares Unlimited a/o Jan 31, 2013
Outstanding Shares 43,040,471 a/o Jan 31, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 34,000,000 a/o Mar 06, 2013
Par Value No Par Value
Shareholders of Record Not Available
Non US Stock Exchange Listing
CUR - Toronto Stock Exchange - Qualified
Short Selling Data
Short Interest 300 (0%)
Jul 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security